DIMENSIONAL FUND ADVISORS LP - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,079,871
-9.9%
973,234
+28.9%
0.01%0.0%
Q2 2023$22,274,154
+54.1%
754,801
+20.3%
0.01%
+40.0%
Q1 2023$14,449,955
+92975.4%
627,325
+12.4%
0.01%0.0%
Q4 2022$15,525
-99.9%
558,258
-8.5%
0.01%
-28.6%
Q3 2022$18,711,000
-28.7%
609,839
-31.6%
0.01%
-22.2%
Q2 2022$26,239,000
-7.1%
891,678
+1.5%
0.01%0.0%
Q1 2022$28,253,000
-18.0%
878,224
+13.7%
0.01%
-10.0%
Q4 2021$34,441,000
+7.6%
772,197
+21.7%
0.01%0.0%
Q3 2021$32,021,000
+25.5%
634,735
+95.1%
0.01%
+25.0%
Q2 2021$25,517,000
+6.2%
325,348
-22.8%
0.01%0.0%
Q1 2021$24,036,000
-36.6%
421,202
-7.0%
0.01%
-42.9%
Q4 2020$37,931,000
+97.8%
452,780
-15.4%
0.01%
+75.0%
Q3 2020$19,175,000
+44.0%
535,119
-2.8%
0.01%
+33.3%
Q2 2020$13,314,000
+34.7%
550,697
-2.3%
0.01%
+20.0%
Q1 2020$9,881,000
+8.7%
563,859
+8.1%
0.01%
+66.7%
Q4 2019$9,087,000
+48.9%
521,666
+31.0%
0.00%
+50.0%
Q3 2019$6,104,000
+43.8%
398,323
+94.7%
0.00%0.0%
Q2 2019$4,246,000204,5420.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders